Search
CT103A
go.drugbank.com/drugs/DB18180InvestigationalCT103A is an investigational BCMA-targeted genetically modified autologous T-cell immunotherapy.
CT120
go.drugbank.com/drugs/DB18181InvestigationalCT120 is an investigational autologous CD19/22 targeted CAR-T cell immunotherapy.
CAM-101
go.drugbank.com/drugs/DB18414InvestigationalCAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.
AVX-470
go.drugbank.com/drugs/DB18455InvestigationalAVX-470 is an anti-tumor necrosis factor (TNF) polyclonal antibody (bovine).
JAK4D
go.drugbank.com/drugs/DB18527ExperimentalJAK4D is a first-in-class thyrotropin-releasing hormone (TRH)-based compound.
TTX-siPDL1
go.drugbank.com/drugs/DB18550ExperimentalTTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.
Cloperastine
go.drugbank.com/drugs/DB09002InvestigationalCloperastine is a cough suppressant that acts on the central nervous system.
Pridopidine
go.drugbank.com/drugs/DB11947InvestigationalPridopidine has been used in trials studying the treatment of Huntington's Disease.
Evatanepag
go.drugbank.com/drugs/DB12022InvestigationalEvatanepag has been used in trials studying the treatment of Tibial Fractures.
Nadifloxacin
go.drugbank.com/drugs/DB12447InvestigationalNadifloxacin has been used in trials studying the treatment of Acne Vulgaris.